Lawood & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$570K Sell
493
-12
-2% -$14.2K 0.39% 50
2026
Q2
$606K Sell
505
-8
-2% -$8.17K 0.41% 52
2026
Q1
$472K Hold
513
– – 0.44% 58
2025
Q4
$551K Buy
+513
New +$491K 0.52% 52

Other funds holding LLY

Lawood & Co's LLY Position: Q3 2026 in Review

Lawood & Co reduced its Eli Lilly (LLY) stake by 2.4% in Q3 2026, selling an estimated $14.2K and leaving 493 shares worth $570K. The position accounts for 0.39% of the portfolio, ranked #50.

Lawood & Co first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $606K in Q2 2026. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Lawood & Co held 493 shares of Eli Lilly worth $570K as of Q3 2026.
  • Lawood & Co sold 12 Eli Lilly shares in Q3 2026, an estimated $14.2K.
  • Eli Lilly made up 0.39% of Lawood & Co's portfolio in Q3 2026, its #50 holding.
  • Lawood & Co first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Lawood & Co's Eli Lilly position peaked at $606K in Q2 2026.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Lawood & Co's 13F filing for Q3 2026, filed 9 Oct 2026.